Henrik Franzyk (HF) has for more than 15 years designed and synthesized biologically active peptides, peptidomimetics and polyamines as well as glycolipids and cationic lipids (both used as adjuvants and/or components for drug delivery by nanoparticles). In these contexts, HF has performed optimization studies of several lead structures via extensive medicinal chemistry.